Delivery Order SPE2DB24D2100-SPE2DB25FBFWK
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $38,612.57 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on July 31, 2025, with completion scheduled for August 1, 2025. This competitive award utilizes firm fixed-price pricing and represents a child contract under the contractor's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $14,837.03 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $17,548.12 delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions. The contract, awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $18,088.96 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in rheumatologic treatment. This competitive contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and operates under firm fixed pricing. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract...
- The Defense Logistics Agency awarded a delivery order valued at $10,782.12 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in rheumatoid arthritis treatment. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $23,637.36 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL, a biologic immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions. This firm fixed-price delivery order, issued on July 30, 2025, with a completion date of July 31, 2025, represents a non-competed award and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract leverages...
- The Defense Logistics Agency awarded a delivery order valued at $3,594.04 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract, which involved no set-aside designation, represents a competitively awarded delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at...
- The Defense Logistics Agency awarded a $28,511.98 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract, awarded on August 11, 2025, with completion targeted for August 12, 2025, utilized firm fixed pricing with no set-aside designation, indicating competitive award to the qualified vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $8,815.75 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed price delivery order, issued on August 12, 2025, with ultimate completion by August 13, 2025, represents a single procurement under the company's larger indefinite delivery contract with DLA. The award was made on a competitive, non-set-aside...
- The Defense Logistics Agency awarded a $17,488.86 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This non-set-aside delivery order is scheduled for ultimate completion on August 4, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFWKDelivery Order
The Defense Logistics Agency awarded a $20,468.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on August 15, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside delivery order represents a continuation of pharmaceutical supply support to federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's Medical Supply Chain and is the place of performance for this contract. The delivery order leverages the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, a $999,999,999 comprehensive global pharmaceutical support vehicle valued through December 2026. Orencia (abatacept) is a biologic immunosuppressant used primarily for the treatment of rheumatoid arthritis and other autoimmune conditions. This delivery order enables the delivery of the specific ClickJect formulation to support military healthcare programs and federal medical systems. AmerisourceBergen Drug Corp's extensive portfolio of federal contract awards demonstrates capability in fulfilling competitive procurement requirements for specialty pharmaceuticals, biologics, and medical supplies across multiple therapeutic domains. The award reflects the company's continued role as a primary supplier of brand-name and generic medications, vaccines, and specialized medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.5k | 8/15/25 |